Jeesun Lee is Clinical Development Director at Shaperon, currently working on a multinational Phase 2b/3 clinical trial of COVID-19 pneumonia. Prior to working at Shaperon, Jeesun has 8 years of experience as a pharmaceutical physician, Medical Manager and Oncology Business Unit Medical Lead from Pfizer Korea, where she worked across diverse Pfizer portfolio and medical affairs’ activities. Jeesun did her Ph.D. in the Department of Clinical Research Design and Evaluation at Sungkyunkwan University, further developing her professional skills within academia and the working field. She is MD from Korea University, South Korea.
